Marie Antoinette Syndrome Following COVID-19 Vaccination

    Maria Efenesia Baffa, Carlo Pipitò, Francesca Montefusco … Roberto Maglie
    Studysummary This report describes a case of alopecia areata presenting as Marie Antoinette syndrome shortly after Pfizer/BioNTech COVID-19 vaccination, with hair regrowth and partial repigmentation following treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Marie Antoinette Syndrome Archives of Dermatology · 2009

    Related research 6

    1. Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss Journal of The American Academy of Dermatology · 2022
    2. Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss Dermatology Reports · 2022
    3. Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata JAAD case reports · 2021
    4. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    5. Topical and Intralesional Therapies for Alopecia Areata Dermatologic therapy · 2011
    6. Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases Dermatologic Therapy · 2011